Growth Stocks

Although growth stock picks can be highly volatile, they can make good long-term investments. They may be well-known stars or quiet gems, but they do share one common attribute—they are growing at a higher-than-average rate within their industry, or within the market as a whole, and could keep growing for years or decades.

And keep in mind that we focus on growth stocks, which have a good long-term history and favourable prospects. We downplay momentum stocks that tend to attract many investors simply because they are moving faster than the market averages, but are liable to fall sharply when their momentum fades.

There’s room for growth stock investing in your portfolio, but make sure you follow our TSI Network three-part Successful Investor strategy for your overall portfolio:

  1. Invest mainly in well-established companies;
  2. Spread your money out across most if not all of the five main economic sectors (Manufacturing & Industry; Resources & Commodities; Consumer; Finance; Utilities);
  3. Downplay or avoid stocks in the broker/media limelight.

Make better stock picks when you read this FREE Special Report, Canadian Growth Stocks: WestJet Stock, RioCan Stock and More.

Read More Close
Growth Stocks Library Archives
These four food and beverage makers face several obstacles to earnings growth, including rising costs for ingredients and labour and higher interest expenses. As a result, they have raised their selling prices to offset those higher input costs. They are also adding new products in response to changing consumer tastes.


We like the long-term prospects of all four, but see only Andrew Peller as a buy for right now.


SAPUTO INC....
Loblaw is ready to thrive in a post-COVID-19 environment. Many of its customers who opted for home delivery (or in-store pickup) during pandemic lockdowns are sticking with that value-added service. The company’s improvements to its loyalty programs should also drive additional spending per visit, both in its stores and on its websites.


The stock lets you tap this growth and the company’s other successful retailing strategies....
Motorola Solutions recently hit a new all-time high of $323, and is now up a whopping 740% since the old Motorola Inc. spun off its cellphone business as a separate firm in January 2011. The remaining operations, which make police radios and related equipment, became Motorola Solutions....
GE HEALTHCARE TECHNOLOGIES INC. $74 is a buy. The company (Nasdaq symbol GEHC; Conservative Growth Portfolio, Manufacturing sector; Shares outstanding: 455.2 million; Market cap: $33.7 billion; Price-to-sales ratio: 1.7; Dividend yield: 0.2%; TSINetwork Rating: Average; www.gehealthcare.com) took its current form in January 2023 when former parent company General Electric Co....
CINTAS CORP. $555 remains a buy for aggressive investors. The stock (Nasdaq symbol CTAS; Aggressive Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 101.9 million; Market cap: $56.6 billion; Price-to-sales ratio: 6.4; Dividend yield: 1.0%; TSINetwork Rating: Average; www.cintas.com) has gained 22% in the past year, hitting a new all-time high of $559 in November 2023....
APPLE INC. $191 is still a hold. The company (Nasdaq symbol AAPL; Aggressive Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 15.6 billion; Market cap: $3.0 trillion; Price-to-sales ratio: 7.9; Dividend yield: 0.5%; TSINetwork Rating: Average; www.apple.com) gets about half of its revenue from iPhone sales....
The shares of these leading foodmakers are all down in the past three months, mainly because investors fear that new weight-loss drugs like Ozempic, which cause people to eat less, will hurt their sales. However, the high cost of these drugs and their serious side effects will limit their use....
AGILENT TECHNOLOGIES INC. $124 is a buy. The company (New York symbol A; Aggressive Growth Portfolio, Manufacturing sector; Shares outstanding: 292.1 million; Market cap: $36.2 billion; Price-to-sales ratio: 5.3; Dividend yield: 0.8%; TSINetwork Rating: Average; www.agilent.com) makes specialized testing equipment for medical research laboratories and industrial clients.


In its fiscal 2023 fourth quarter, ended October 31, 2023, revenue fell 8.7%, to $1.69 billion from $1.85 billion a year earlier....
We think the drug industry will enjoy great success over the next decade. But due to the nature of the business, results will vary widely and unpredictably from one drug company to another. A volatile market like the one we expect for drug stocks will include winners and losers....
The coronavirus pandemic forced the cancellation of most vacation plans. However, the reopening of the economy has spurred strong demand for travel. Wyndham Hotels & Resorts continues to benefit from that surge—and has now attracted a takeover bid.


WYNDHAM HOTELS & RESORTS, $76.80, is a buy. The company (New York symbol WH; TSINetwork Rating: Extra Risk) (www.wyndhamhotels.com; Shares o/s: 83.0 million; Market cap: $6.4 billion; Yield: 1.8%) is the world’s largest hotel franchiser, with 851,500 rooms across 9,100 hotels in 95 countries.


Wyndham has rejected an unsolicited takeover bid from rival Choice Hotels International (symbol CHH on New York)....